1. saqarTveloSi tuberkulozis kontrolis erovnuli gegmis proeqti
arCil salayaia
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

2. mizani
saqarTveloSi tuberkulozis kontrolis 5-wliani gegmis ( ) mizania sikvdilobis, avadobisa da infeqciis gavrcelebis Semcireba da medikamentebisadmi rezistentobis ganviTarebis prevencia, riTac Semcirdeba tuberkuloziT gamowveuli social-ekonomikuri tvirTi ojaxebsa da sazogadoebaze
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

3. amocanebi
maRali xarisxis DOTS strategiis danergvis Semdgomi gafarToeba-gaZliereba
2. multirezistentuli tuberkulozis mkurnalobisaTvis aucilebeli pirobebis Seqmna da DOTS + strategiis danergva
3. tuberkulozis kontrolis integracia jandacvis sistemis reformaSi
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

4. amocanebi (gagrZeleba)
farTo TanamSromlobis uzrunvelyofa tuberkulozi/aiv koinfeqciis kontrolis erToblivi RonisZiebebis gansaxorcieleblad
pacientebisa da sazogadoebis Tanamonawileoba tuberkulozis kontrolSi da tuberkulozTan asocirebuli stigmis Semcireba
6. tuberkulozTan dakavSirebuli kvlevebis mxardaWera
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

5. misaRwevi indikatorebi
2007 wlisTvis
gamovlenis maCvenebeli unda iyos 70%-ze meti;
warmatebuli mkurnalobis maCvenebeli unda iyos 85%-ze meti
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

6. misaRwevi indikatorebi (gagrZeleba)
2010 wlisTvis
multirezistentuli tuberkuloziT daavadebuli yvela pacientisaTvis xelmisawvdomi unda iyos DOTS + -iT mkurnaloba;
multirezitentuli tuberkulozis warmatebuli mkurnalobis maCvenebelma unda miaRwios 60%-s
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

7. misaRwevi indikatorebi (gagrZeleba)
2011 wlisTvis
unda daiwyos tuberuloziT avadobis kleba;
unda daiwyos multirezistenuli tuberkuloziT avadobis kleba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

8. maRali xarisxis DOTS strategiis danergvis Semdgomi gafarToeba-gaZliereba (amocana 1)
tuberkulozis kontrolis politikuri mxardaWera
tuberkulozis SemTxvevaTa gamovlena
standartuli mkurnaloba da pacientis mxardaWera
tubsawinaaRmdego medikamentebiT momaragebisa da marTvis efeqturi sistema
monitoringis sistema da Sedegebis Sefaseba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

9. tuberkulozis kontrolis politikuri mxardaWera
tuberkulozis kontrolis mzardi da stabiluri finansuri uzrunvelyofa
tuberkulozis kontrolis koordinacia
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

10. tuberkulozis SemTxvevaTa gamovlena
naxvelis nacxis mikroskopuli gamokvleva
baqteriologiur laboratoriaTa reorganizacia-optimizacia
laboratoriaTa da naxvelis Semgrovebeli punqtebis aRWurva da momarageba
gamosakvlevi masalis transportireba (naxvelis Semgrovebeli punqtebidan baqterioskopul laboratoriebSi, baqterioskopuli laboratoriebidan ki - erovnul referens laboratoriaSi)
xarisxis kontrolis ganxorcieleba erovnuli referens laboratoriis mier, laboratoriis TanamSromlebis uwyveti swavlebis uzrunvelyofa janmo-s rekomendaciebis Sesabamisad
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

11. tuberkulozis SemTxvevaTa gamovlena (gagrZeleba)
kulturaluri gamokvleva da tubsawinaaRmdego wamlebisadmi mgrZnobelobis gansazRvra
I etapi, ww, baqterioskopulad da klinikurad dadgenili tuberkulozis yvela SemTxvevis kulturaluri dadastureba
II etapi, ww, kulturaluri gamokvleva tuberkulozze yvela eWvmitanilis da tubdaavadebulisa
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

12. tuberkulozis SemTxvevaTa gamovlena (gagrZeleba)
SemTxvevaTa aqtiuri gamovlena
filtvis aqtiuri tuberkuloziT daavadebulTan (mgb +) kontaqtSi myofi pirebi
sasjelaRsrulebis dawesebulebebSi myofi pirebi
aiv-inficirebuli pirebi
wvevamdelebi
saWiroebis SemTxvevaSi mosaxleobis sxva SerCeuli jgufebi (mag.: iZulebiT gadaadgilebuli pirebi da intravenuri narkomanebi)
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

13. standartuli mkurnaloba da pacientis mxardaWera
standartuli mkurnaloba uSualo meTvalyureobis qveS (DOT)
pacientze orientirebuli samedicino daxmareba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

14. tubsawinaaRmdego medikamentebiT momaragebisa da marTvis efeqturi sistema
tubsawinaaRmdego medikamentebis Sesyidvisa da ganawilebis dagegmva
tubsawinaaRmdego medikamentebis gavrcelebis samarTlebrivi regulacia
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

15. registracia-angariSgebis sistema
qveyanaSi unda arsebobdes erTiani unificirebuli registracia-angariSgebis sistema (maT Soris samoqalaqo da penitencialur seqtorSi)
qveyanaSi unda arsebobdes tuberkulozis registrirebuli SemTxvevebis erTiani erovnuli monacemTa baza
laboratoriuli Sedegebis angariSgebis integrireba tuberkulozis registracia-angariSgebis sistemaSi
angariSgebis eleqtronuli sistemebis danergva
TiToeuli samedicino dawesebulebis (maT Soris, kerZo praqtikis eqimebis) mier tuberkulozis yvela SemTxvevis erTiani monacemTa bazisaTvis savaldebulo Setyobinebis uzrunvelyofa
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

16. DOTS plus strategiis danergva (amocana 2)
DOTS + da misi danergvis etapebi
mkurnaloba
laboratoria
infeqciis kontroli
swavleba
zedamxedveloba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

17. DOTS + da misi danergvis etapebi
2006 wlisTvis
MSF-is mxardaWeriT iwyeba piloturi proeqti
organizaciebis ICRC da GOPA/KfW mxardaWeriT iwyeba piloturi proeqti penitencialur sistemaSi
tuberkulozis erovnuli programa waradgens ganacxads “mwvane Suqis komitetSi” globaluri fondis proeqtiT dafinansebuli DOTS plus mkurnalobis gansaxorcieleblad
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

18. DOTS + da misi danergvis etapebi
2007 wlisTvis
unda damTavrdes tuberkulozisa da filtvis daavadebaTa erovnuli centris axali Senobis mSenebloba da arsebuli Senobis rekonstruqcia
globaluri fondis proeqtiT dafinansdeba 50 multirezistentuli pacientis mkurnaloba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

19. DOTS + da misi danergvis etapebi
wlebisTvis
globaluri fondi daafinansebs 100 multirezistentuli pacientis mkurnalobas
saxelmwifom unda uzrunvelyos finansuri mxardaWera, raTa daifaros sxvaoba donoruli proeqtebiT uzrunvelyofil mkurnalobasa da realur saWiroebas Soris (300 pacienti wliurad)
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

20. multirezistentuli tuberkulozis mkurnalobis principebi
individualizirebuli mkurnaloba meore rigis antituberkulozuri medikamentebiT
uSualo meTvalyureoba wamlis TiToeuli dozis miRebaze
gverdiTi movlenebis sakoreqcio medikamentebi
stacionari (qirurgiuli ganyofilebis CaTvliT), romelSic tardeba mkurnaloba, unda akmayofilebdes specialur standartebs
ambulatoriuli mkurnalobisTvis unda arsebobdes gamarTuli infrastruqtura
pacientebisa da maTi ojaxebisTvis mxardaWera
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

21. DOTS + laboratoriuli momsaxureba
simZlavreebis gazrda, raTa uzrunvelyofil iyos yvela eWvmitanilisa da daavadebulis baqteriologiuri gamokvleva
II rigis tubsawinaaRmdego medikamentebis mimarT mgrZnobelobis testis danergva
kulturaluri gamokvlevisa da mgrZnobelobis ganmsazRvreli avtomatizebuli sistemebis danergva
infeqciis kontrolis gaumjobeseba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

22. tuberkulozis kontrolis integracia jandacvis sistemis reformaSi (amocana 3)
tuberkulozis erovnuli programis statusi da organizaciuli struqtura
tuberkulozis kontroli penitencialur sistemaSi
pirveladi jandacvisa da tubsamsaxurebis integracia
samedicino ganaTleba da gadamzadeba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

23. erovnuli programis struqtura da funqciebi
centraluri done
tuberkulozisa da filtvis daavadebaTa erovnuli centri
marTvis samsaxuri
sauniversiteto, referaluri klinika
erl
programis
Sefasebis
da dagegmvis
samsaxuri
centraluri
afTiaqi da
uzrunvelyofis
samsaxuri
stacionari
ambulatoria
samecniero
kvlevebis
koordinaciis
samsaxuri
erovnuli
monacemTa
baza
supervizia da
adamianuri
resursebis
ganviTareba
regionaluri done
reg. koordinatori reg. dispanseri
(sawolebiT an
sawolebis gareSe).
tuberkulozis
koordinatori penitencialuri
penitencialur sistema
sistemaSi
tuberkulozis ganyofileba
fsiqonevrologiur saavadmyofoSi
raionuli done
kabineti
dispanseri
pjr
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

24. tuberkulozi/aiv koinfeqciis mkurnalobisa da kontrolis erToblivi RonisZiebebis ganxorcieleba (amocana 4)
tuberkuloziT gamowveuli tvirTis Semcireba aiv/SidsiT daavadebulTa Soris
aiv-infeqciiT gamowveuli tvirTis Semcireba tuberkuloziT daavadebulTa Soris
tuberkulozisa da aiv/Sidsis koinfeqciis mkurnaloba
aiv/tuberkulozis erToblivi RonisZiebebis monitoringi da Sefaseba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

25. pacientebisa da sazogadoebis Tanamonawileoba tuberkulozis kontrolSi da tuberkulozTan asocirebuli stigmis Semcireba (amocana 5)
sazogadoebis ganswavlis strategia
sazogadoebis monawileoba
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases

26. tuberkulozTan dakavSirebuli kvlevebis mxardaWera (amocana 6)
operaciuli kvlevebi
samecniero kvlevebi saqarTveloSi globaluri miznebis konteqstSi
Archil Salakaia, MD. MPH
Executive Director.
National Center for Tuberculosis and Lung Diseases